Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches
Many carcinogen- and human papilloma virus (HPV)-associated head and neck cancers (HNSCC) display a hematopoietic cell infiltrate indicative of a T-cell inflamed phenotype and an underlying anti-tumor immune response. However, by definition, these tumors have escaped immune elimination and formed a...
Main Authors: | Clint T. Allen, Paul E. Clavijo, Carter Van Waes, Zhong Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/7/4/0900 |
Similar Items
-
Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
by: Shixiang Wang, et al.
Published: (2019-11-01) -
Tumor suppressor maspin as a modulator of host immune response to cancer
by: Sijana H. Dzinic, et al.
Published: (2015-10-01) -
The Role of Antigen Processing and Presentation in Cancer and the Efficacy of Immune Checkpoint Inhibitor Immunotherapy
by: Anastasia Mpakali, et al.
Published: (2021-01-01) -
A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
by: Tuxiong Huang, et al.
Published: (2020-07-01) -
Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells
by: Yvette Robbins, et al.
Published: (2020-07-01)